Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-Opioid vs Opioid for Post-Operative Breakthrough Pain
NCT04813991Phase 3Withdrawn
- Sponsor
- Hackensack Meridian Health
- Start
- Mar 2022
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen in perioperative pain, sponsored by Hackensack Meridian Health. Planned start Mar 2022; status: withdrawn.
02
Drugs
ibuprofen
03
Conditions
perioperative pain
Beyond the preview
Go deeper on NCT04813991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04813991.